Negative association of concomitant physical symptoms with the course of major depressive disorder: A systematic review

Journal of Psychosomatic Research

Volumn 68, Issue 6, 2010, Pages 511-519

  Huijbregts, Klaas M L ^a,b   van der Feltz Cornelis, Christina M ^a,b,d   van Marwijk, Harm W J ^b   de Jong, Fransina J ^a,b   van der Windt, Daniëlle A W M ^b,c   Beekman, Aartjan T F ^b  

^a NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c KEELE UNIVERSITY   (United Kingdom)

^d TILBURG UNIVERSITY   (Netherlands)

Author keywords

Comorbidity; Depression; Effect modifiers (epidemiology); Physical symptoms; Somatisation; Systematic review

Indexed keywords

DESIPRAMINE; FLUOXETINE; IMIPRAMINE; LITHIUM; MAPROTILINE; MIANSERIN; NORTRIPTYLINE; PHENELZINE; SELEGILINE;

DISEASE ASSOCIATION; DISEASE COURSE; DRUG DOSE INCREASE; HUMAN; MAJOR DEPRESSION; PROGNOSIS; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGICAL RATING SCALE; PSYCHOTHERAPY; REVIEW; SCORING SYSTEM; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; TREATMENT RESPONSE;

ANTIDEPRESSIVE AGENTS; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; DIAGNOSIS, DIFFERENTIAL; FAMILY PRACTICE; HUMANS; MASS SCREENING; PERSONALITY INVENTORY; PROSPECTIVE STUDIES; PSYCHOMETRICS; PSYCHOPHYSIOLOGIC DISORDERS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; SOMATOFORM DISORDERS; TREATMENT OUTCOME;

EID: 77952956312     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2009.11.009     Document Type: Review

References (33)

1. Murray CJ, Lopez AD Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997, 349:1498-1504.
2. Feinstein AR. Clinical epidemiology: the architecture of clinical research 1985, 219. WB Saunders, Philadelphia.
3. Gaynes BN, Rush AJ, Trivedi MH, Wisniewski SR, Balasubramani GK, McGrath PJ, et al. Primary versus specialty care outcomes for depressed outpatients managed with measurement-based care: results from STAR*D. J Gen Intern Med 2008, 551-560.
4. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D Report. Am J Psychiatry 2006, 163:1905-1917.
5. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depressive disorder: results from the national comorbidity survey replication (NCS-R). JAMA 2003, 23:3095-3104.
6. Trivedi MH, Cory-Lisle PK, Guo Z, Lennox RD, Pikalov A, Kim E Remission, response without remission, and nonresponse in major depressive disorder: impact on functioning. Int Clin Psychopharmacol 2009, 24:133-138.
7. Simon GE, Vonkorff M, Piccinelli M, Fullerton C, Ormel J An international study of the relation between somatic symptoms and depression. N Engl J Med 1999, 341:1329-1335.
8. Mergl R, Seidscheck I, Allgaier AK, Möller HJ, Hegerl U, Henkel V Depressive, anxiety, and somatoform disorders in primary care: prevalence and recognition. Depress Anxiety 2007, 24:185-195.
9. Kroenke K, Spitzer RL, Williams JB, Linzer M, Hahn SR, deGruy FV, et al. Physical symptoms in primary care. Predictors of psychiatric disorders and functional impairment. Arch Fam Med 1994, 3:774-779.
10. Kroenke K Patients presenting with somatic complaints: epidemiology, psychiatric comorbidity and management. Int J Methods Psychiatr Res 2003, 12:34-43.
11. Bair MJ, Robinson RL, Katon W, Kroenke K Depression and pain comorbidity. Arch Intern Med 2003, 163:2433-2445.
12. Hamilton M A rating scale for depression. J Neurol Neurosurg Psychiatry 1960, 23:56-62.
13. Licht-Strunk E, van der Windt DA, van Marwijk HW, de Haan M, Beekman AT The prognosis of depression in older patients in general practice and the community. A systematic review. Fam Pract 2007, 24:168-180.
14. Kuijpers T, van der Windt DA, van der Heijden GJ, Bouter LM Systematic review of prognostic cohort studies on shoulder disorders. Pain 2004, 109:420-431.
15. Hudak PL, Cole DC, Frank JW Perspectives on prognosis of soft tissue muscoskeletal disorders. Int J Rehabil Res 1998, 21:2940.
16. Altman DG Systematic reviews of evaluations of prognostic variables. Br Med J 2001, 323:224-228.
17. Sacket DL, Straus SE, Richardson WS. Evidence-based medicine. how to practice and teach EBM. Guidelines 2000, Chuchill Livingstone, Edinburgh.
18. Ariëns GA, van Mechelen W, Bongers PM, Bouter LM, van der Wal G Physical risk factors for neck pain. Scand J Work Environ Health 2000, 26:7-19.
19. Moher D, Liberati A, Tetzlaff J, Altman DG Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. PLoS Med 2009, 6:1-6. the PRISMA Group.
20. Karp JF, Scott J, Houck P, Reynolds CF, Kupfer DJ, Frank E Pain predicts longer time to remission during treatment of recurrent depression. J Clin Psychiatry 2005, 66:591-597.
21. Papakostas GI, Petersen TJ, Iosifescu DV, Summergrad P, Sklarsky BA, Alpert JE, et al. Somatic symptoms as predictors of time to onset of response to fluoxetine in major depressive disorder. J Clin Psychiatry 2004, 65:546-643.
22. Papakostas GI, Petersen T, Denninger J, Sonawalla SB, Mahal Y, Alpert JE, et al. Somatic symptoms in treatment-resistant depression. Psychiatry Res 2003, 118:39-45.
23. Papakostas GI, McGrath P, Stewart J, Charles D, Chen Y, Mischoulon D, et al. Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder. Psychiatry Res 2008, 161:116-120.
24. Keeley RD, Smith JL, Nutting PA, Miriam DL, Perry DW, Rost KM Does a depression intervention result in improved outcomes for patients presenting with physical symptoms?. J Gen Intern Med 2004, 19:615-623.
25. Hoencamp E, Haffmans PMJ, Duivenvoorden H, Knegtering H, Dijken WA Predictors of (non)-response in depressed outpatients treated with a three-phase sequential medication strategy. J Affect Disord 1994, 31:235-246.
26. Papakostas GI, Petersen T, Hughes ME, Nierenberg AA, Alpert JE, Fava M Anxiety and somatic symptoms as predictors of treatment-related adverse events in major depressive disorder. Psychiatry Res 2004, 126:287-290.
27. Agosti V, Quitkin FM, Stewart JW, McGrath PJ Somatization as a predictor of medication discontinuation due to adverse events. Int Clin Psychopharmacol 2002, 17:311-324.
28. Rollman BL, Block MR, Schulberg HC Symptoms of major depression and tricyclic side effects in primary care patients. J Gen Intern Med 1997, 12:284-291.
29. Spitzer RL, Endicott J, Robins E Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry 1978, 35:773-782.
30. Derogatis LR, Lazarus L. SCL-90-R, brief symptom inventory, and matching clinical rating scales. The use of psychological testing for treatment planning and outcome assessment 1994, 217-248. Erlbaum, Hillsdale, New Jersey. M. Marish (Ed.).
31. Hiller W, Janca A Assessment of somatoform disorders: a review of strategies and instruments. Acta Neuropsychiatrica 2003, 15:167-179.
32. Unützer J, Katon W, Callahan CM, Williams JW, Hunkeler E, Harpole L, et al. Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA 2002, 288:2836-2845.
33. Van der Feltz-Cornelis CM, van Oppen P, Adèr HJ, van Dyck R Randomised controlled trial of a collaborative care model with psychiatric consultation for persistent medically unexplained symptoms in general practice. Psychother Psychosom 2006, 75:282-289.